Yüklüyor......
Elafin promotes tumour metastasis and attenuates the anti-metastatic effects of erlotinib via binding to EGFR in hepatocellular carcinoma
BACKGROUND: Elafin is a serine protease inhibitor critical for host defence. We previously reported that Elafin was associated with the recurrence of early-stage hepatocellular carcinoma (HCC) after surgery. However, the exact role of Elafin in HCC remains obscure. METHODS: HCC tissue microarrays we...
Kaydedildi:
| Yayımlandı: | J Exp Clin Cancer Res |
|---|---|
| Asıl Yazarlar: | , , , , , , , , , , , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
BioMed Central
2021
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7995733/ https://ncbi.nlm.nih.gov/pubmed/33771199 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13046-021-01904-y |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|